N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis
- PMID: 2435835
- PMCID: PMC2188568
- DOI: 10.1084/jem.165.4.1207
N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis
Abstract
Antibodies induced in mice by the N-propionyl (N-Pr)-group B meningococcal polysaccharide (GBMP)-tetanus toxoid (TT) conjugate were bactericidal for GBM organisms independent of protein serotype. The antisera contained two populations of N-Pr-GBMP-specific antibodies, only one of which crossreacted with the GBMP. Particularly significant was the fact that the bactericidal activity was mainly associated with the population of antibodies that did not crossreact with the GBMP. Therefore it can be inferred from the above evidence that the N-Pr-GBMP mimics a unique epitope on the surface of GBM organisms that is not present on the exogenous GBMP.
Similar articles
-
N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.J Exp Med. 1997 Jun 2;185(11):1929-38. doi: 10.1084/jem.185.11.1929. J Exp Med. 1997. PMID: 9166422 Free PMC article.
-
Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide.Microb Pathog. 1989 Jun;6(6):455-8. doi: 10.1016/0882-4010(89)90087-9. Microb Pathog. 1989. PMID: 2505013
-
Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.J Immunol. 1986 Sep 1;137(5):1708-13. J Immunol. 1986. PMID: 3091688
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
The immune response to the capsular polysaccharide of Neisseria meningitidis group B.Zentralbl Bakteriol. 1997 Feb;285(3):331-40. doi: 10.1016/s0934-8840(97)80001-1. Zentralbl Bakteriol. 1997. PMID: 9084108 Review. No abstract available.
Cited by
-
Vaccines for prevention of meningococcal disease.Clin Microbiol Rev. 1989 Apr;2 Suppl(Suppl):S134-8. doi: 10.1128/CMR.2.Suppl.S134. Clin Microbiol Rev. 1989. PMID: 2497956 Free PMC article. Review. No abstract available.
-
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci.J Exp Med. 2006 Jan 23;203(1):111-8. doi: 10.1084/jem.20051540. Epub 2006 Jan 3. J Exp Med. 2006. PMID: 16390937 Free PMC article.
-
Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.Infect Immun. 1993 May;61(5):1873-80. doi: 10.1128/iai.61.5.1873-1880.1993. Infect Immun. 1993. PMID: 8478076 Free PMC article.
-
Review of meningococcal group B vaccines.Clin Infect Dis. 2010 Mar 1;50 Suppl 2(S2):S54-65. doi: 10.1086/648966. Clin Infect Dis. 2010. PMID: 20144017 Free PMC article. Review.
-
Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.Antonie Van Leeuwenhoek. 1990 Jun;58(1):1-47. doi: 10.1007/BF02388078. Antonie Van Leeuwenhoek. 1990. PMID: 2195989 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials